Academic Journal

Metastatic Prostatic Ductal Adenocarcinoma Successfully Treated with Docetaxel Chemotherapy: A Case Report

التفاصيل البيبلوغرافية
العنوان: Metastatic Prostatic Ductal Adenocarcinoma Successfully Treated with Docetaxel Chemotherapy: A Case Report
المؤلفون: Fujiwara, Ryo, Kageyama, Susumu, Tomita, Keiji, Hanada, Eiki, Tsuru, Teruhiko, Yoshida, Tetsuya, Narita, Mitsuhiro, Isono, Takahiro, Kawauchi, Akihiro
المصدر: Case Reports in Oncology ; volume 8, issue 2, page 339-344 ; ISSN 1662-6575
بيانات النشر: S. Karger AG
سنة النشر: 2015
الوصف: A 68-year-old man presented with gross hematuria. A papillary urethral tumor adjacent to the verumontanum was found by cystourethroscopy. Serum prostate-specific antigen (PSA) was 3.246 ng/ml. A transurethral biopsy specimen was most suggestive of a primary urothelial carcinoma of the prostate, for which a radical cystoprostatectomy was performed. The final pathology was prostatic ductal adenocarcinoma with very focal acinar features (Gleason score 5 + 4 = 9, pT3bN0M0). Local recurrence and pelvic bone metastases developed 17 months later, and his PSA rose to 10.806 ng/ml. He was treated with combined androgen blockade and radiation. Two years later, the lesion showed progressive growth. Treatment followed with docetaxel (70 mg/m 2 every 3 weeks) and prednisolone 5 mg twice daily. After 10 cycles of chemotherapy, all lesions disappeared and PSA decreased to <0.005 ng/ml. Three years after chemotherapy, he maintains a complete response without any additional treatments. Docetaxel chemotherapy can be an effective treatment for patients with recurrent prostatic ductal adenocarcinoma.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1159/000438785
الاتاحة: http://dx.doi.org/10.1159/000438785
https://www.karger.com/Article/Pdf/438785
Rights: https://creativecommons.org/licenses/by-nc/3.0/ ; https://creativecommons.org/licenses/by-nc/3.0/
رقم الانضمام: edsbas.C5760146
قاعدة البيانات: BASE